SGMT
Sagimet Biosciences·NASDAQ
--
--(--)
--
--(--)
3.81 / 10
Netural
Fund flow metrics score 7.62/10, revealing robust fund flow characteristics. Beneficial no significant trends trends are challenged by problematic overall, block, Small, Medium, Large, and Extra-large signals, indicating positive capital movement. Analyst perspective reveals predominantly positive analyst sentiment with moderate confidence. Rating breakdown: Strong Buy(66.7%), Neutral(33.3%) from 3 analyst assessments, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-03
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for SGMT?
- SGMT holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.81/10 (Netural).
